NCT01018225View on ClinicalTrials.gov

Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2009

Study Completion Date

July 31, 2010

Conditions
Nocturia
Interventions
DRUG

darifenacin

7.5 or 15 mg darifenacin, once a day for 6 weeks

DRUG

Placebo

Placebo pill, once a day, for six weeks

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Cognitive Research Corporation

INDUSTRY